These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25610523)

  • 21. Hyperdilution of CaHA fillers for the improvement of age and hereditary volume deficits in East Asian patients.
    Chao YY; Kim JW; Kim J; Ko H; Goldie K
    Clin Cosmet Investig Dermatol; 2018; 11():357-363. PubMed ID: 30038511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium hydroxylapatite filler: an overview of safety and tolerability.
    Pavicic T
    J Drugs Dermatol; 2013 Sep; 12(9):996-1002. PubMed ID: 24002146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicenter, 47-month study of safety and efficacy of calcium hydroxylapatite for soft tissue augmentation of nasolabial folds and other areas of the face.
    Sadick NS; Katz BE; Roy D
    Dermatol Surg; 2007 Dec; 33 Suppl 2():S122-6; discussion S126-7. PubMed ID: 18086049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of calcium hydroxylapatite (Radiesse) in nonsurgical aesthetic rejuvenation.
    Lizzul PF; Narurkar VA
    J Drugs Dermatol; 2010 May; 9(5):446-50. PubMed ID: 20480786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete biodegradable nature of calcium hydroxylapatite after injection for malar enhancement: an MRI study.
    Pavicic T
    Clin Cosmet Investig Dermatol; 2015; 8():19-25. PubMed ID: 25709485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the rheological properties of viscosity and elasticity in two categories of soft tissue fillers: calcium hydroxylapatite and hyaluronic acid.
    Sundaram H; Voigts B; Beer K; Meland M
    Dermatol Surg; 2010 Nov; 36 Suppl 3():1859-65. PubMed ID: 20969663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of monopolar radiofrequency treatment over soft-tissue fillers in an animal model.
    England LJ; Tan MH; Shumaker PR; Egbert BM; Pittelko K; Orentreich D; Pope K
    Lasers Surg Med; 2005 Dec; 37(5):356-65. PubMed ID: 16240419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reshaping the Lower Face Using Injectable Fillers.
    Braz A; Eduardo CCP
    Indian J Plast Surg; 2020 Aug; 53(2):207-218. PubMed ID: 32884187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 52-month summary of results using calcium hydroxylapatite for facial soft tissue augmentation.
    Tzikas TL
    Dermatol Surg; 2008 Jun; 34 Suppl 1():S9-15. PubMed ID: 18547188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pilot Study Examining the Safety and Efficacy of Calcium Hydroxylapatite Filler With Integral Lidocaine Over a 12-Month Period to Correct Temporal Fossa Volume Loss.
    Juhász MLW; Levin MK; Marmur ES
    Dermatol Surg; 2018 Jan; 44(1):93-100. PubMed ID: 28858938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium hydroxylapatite for facial rejuvenation.
    Berlin A; Cohen JL; Goldberg DJ
    Semin Cutan Med Surg; 2006 Sep; 25(3):132-7. PubMed ID: 17055392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Injectable Filler Techniques for Facial Rejuvenation, Volumization, and Augmentation.
    Bass LS
    Facial Plast Surg Clin North Am; 2015 Nov; 23(4):479-88. PubMed ID: 26505544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe ocular complications following facial calcium hydroxylapatite injections: Two case reports.
    Hsieh YH; Lin CW; Huang JS; Yeh PT
    Taiwan J Ophthalmol; 2015; 5(1):36-39. PubMed ID: 29018663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orbital augmentation with injectable calcium hydroxylapatite for correction of postenucleation/evisceration socket syndrome.
    Vagefi MR; McMullan TF; Burroughs JR; Georgescu D; McCann JD; Anderson RL
    Ophthalmic Plast Reconstr Surg; 2011; 27(2):90-4. PubMed ID: 20683373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 12-point Revitalization Guide to Pan-facial Application of Injectable Fillers in Older Women.
    Corduff N
    J Clin Aesthet Dermatol; 2018 Aug; 11(8):35-40. PubMed ID: 30214665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overview of Deep Dermal Fillers.
    Liu MH; Beynet DP; Gharavi NM
    Facial Plast Surg; 2019 Jun; 35(3):224-229. PubMed ID: 31189194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of voice outcome after vocal fold augmentation with fat or calcium hydroxylapatite.
    Lodder WL; Dikkers FG
    Laryngoscope; 2015 May; 125(5):1161-5. PubMed ID: 25545723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium Hydroxylapatite With Integral Lidocaine Provides Improved Pain Control for the Correction of Nasolabial Folds.
    Schachter D; Bertucci V; Solish N
    J Drugs Dermatol; 2016 Aug; 15(8):1005-10. PubMed ID: 27538003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic review of filler agents for aesthetic treatment of HIV facial lipoatrophy (FLA).
    Jagdeo J; Ho D; Lo A; Carruthers A
    J Am Acad Dermatol; 2015 Dec; 73(6):1040-54.e14. PubMed ID: 26481056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiance FN: a new soft tissue filler.
    Sklar JA; White SM
    Dermatol Surg; 2004 May; 30(5):764-8; discussion 768. PubMed ID: 15099322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.